James Randolph Hunter Jr.
CIK: 0002071788
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TNXP
Tonix Pharmaceuticals Holding Corp.
Director
Discretionary Trading P&L
Holdings
About Hunter James Randolph Jr
Hunter James Randolph Jr (SEC CIK 0002071788) files insider reports with the SEC as Director of Tonix Pharmaceuticals Holding Corp. (TNXP).
Signal8 holds 3 ownership filings by Hunter James Randolph Jr (1 Form 3, 2 Form 4), filed between Jun 13, 2025 and May 14, 2026. Those filings report 2 transactions, from Jun 12, 2025 to May 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hunter James Randolph Jr's filings is in BERKELEY HEIGHTS, NJ.
Recent filings by Hunter James Randolph Jr
Other insiders filing for Tonix Pharmaceuticals Holding Corp. (TNXP)
- Englese Thomas, Chief Commercial Officer
- BAGGER RICHARD H, Director
- SAENGER BRADLEY, Chief Financial Officer
- Taylor Carolyn E., Director
- Stillwell Richard Newcomb, Director
- LEDERMAN SETH, Chief Executive Officer